Pretherapeutic 124I dosimetry reliably predicts intratherapeutic blood kinetics of 131I in patients with differentiated thyroid carcinoma receiving high therapeutic activities.
Autor: | Ruhlmann, Marcus, Sonnenschein, Wilfried, Nagarajah, James, Binse, Ina, Herrmann, Ken, Jentzen, Walter |
---|---|
Zdroj: | Nuclear Medicine Communications; May2018, Vol. 39 Issue 5, p457-464, 8p |
Databáze: | Complementary Index |
Externí odkaz: |